e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Public Health and Surveillance
- 2 JMIR Research Protocols
- 1 JMIR Formative Research
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Interim findings of the PURPOSE 1 trial presented at the AIDS 2024 Conference confirm that lenacapavir, a long-acting injectable Pr EP technology that can be taken twice a year, offered 100% protection against HIV transmission among cisgender women enrolled [7]. However, less than 2% of eligible Black cisgender women in the United States take Pr EP [8].
JMIR Public Health Surveill 2025;11:e67367
Download Citation: END BibTex RIS
Consistently, existing studies have recognized that sexual minority individuals experience significantly worse sleep quality than their cisgender and heterosexual peers.
JMIR Public Health Surveill 2025;11:e53549
Download Citation: END BibTex RIS
HIV pre-exposure prophylaxis (Pr EP) is a safe and proven biomedical strategy to prevent HIV transmission among cisgender women [1-3]. However, Black cisgender women remain underrepresented throughout the Pr EP care continuum compared to their White counterparts [4,5].
JMIR Res Protoc 2024;13:e59975
Download Citation: END BibTex RIS
Initiatives for ending the HIV epidemic in the United States must include cisgender women. Among ~37,000 people diagnosed with HIV annually in the United States, 19% are cisgender women, with the majority (~60%) of new HIV diagnoses among cisgender women occurring in the South [1,2]. Georgia has the highest rate of new HIV diagnoses (21% occur among cisgender women), and also has one of the highest rates of perinatal HIV infection [1,3].
JMIR Res Protoc 2024;13:e56293
Download Citation: END BibTex RIS
Transgender people in the United States are at increased risk for HIV and other sexually transmitted infections (STIs) compared to their cisgender counterparts [1]. Although transgender women account for most new HIV diagnoses among transgender people [2], transgender men and other gender-diverse people assigned female at birth who have sex with men also experience disproportionate HIV risk [3].
JMIR Form Res 2023;7:e51055
Download Citation: END BibTex RIS